NEW YORK (TheStreet) -- RATINGS CHANGES
Accorda (ACOR) was upgraded at FBR Capital Markets to outperform from market perform. Valuation call, based on a $47 price target, FBR Capital Markets said.
Allegheny (ATI) was upgraded at Sterne Agee to neutral from underperform. Twelve-month price target is $39. Pricing trends are improving, Sterne Agee said.
Bloomin Brands (BLMN) was upgraded at Deutsche Bank to buy from hold. Twelve-month price target is $27. Stock is attractive, following the recent market pullback, Deutsche bank said.
Must Read: Analysts' Actions: F GLW GPS ETFC GG
Boston Scientific (BSX) was upgraded to buy at Bank of America/Merrill Lynch. Twelve-month price target is $16. Stock has come off its highs, but the company has an attractive pipeline, BofA/Merrill Lynch said.
Community Health (CYH) was upgraded at Oppenheimer to outperform from perform. Twelve-month price target is $55. Company has compelling long-term earnings growth opportunity, Oppenheimer said.
Ecopetrol (EC) was upgraded to buy at TheStreet Ratings.
Edwards Lifesciences (EW) was upgraded at J.P. Morgan to neutral from underweight. Twelve-month price target is $78. CoreValve injunction has materially altered the industry landscape, J.P. Morgan said.
Eaton Vance (EV) was upgraded at Citigroup to neutral. Twelve-month price target is $35. Stock has lagged, but the company's asset base is defensive, Citigroup said.
F5 Networks (FFIV) was upgraded at Stifel Nicolaus to buy from hold. Twelve-month price target is $120. Checks suggest higher near-term growth, Stifel Nicolaus said.
Full House Resorts (FLL) was downgraded to sell at TheStreet Ratings.
Hyatt (H) was upgraded at FBR Capital Markets to market perform from outperform. Valuation call, based on a 12-month price target of $62, FBR Capital Markets said.